New challenges: long-term TKI therapy in an ageing patient population video
Speaker: Dr Alex Lyon
Dr. Alex Lyon is a Senior Lecturer in Cardiology at Imperial College, London and a Consultant Cardiologist at the Royal Brompton Hospital. Alex has been the Clinical Lead for the cardio-oncology service at the Royal Brompton Hospital since 2011, specialising in surveillance and cardioprotection from modern cancer drugs, risk stratification and treatment of all cardiac complications of cancer treatment.
His clinical interests are in the fields of heart failure, cardio-oncology including chemotherapy cardiomyopathy and the cardiovascular complications of modern cancer therapies, Takotsubo syndrome and the effects of major stresses of the heart and the development of novel therapeutics including gene therapy for chronic heart failure. Alex has published 111 scientific papers in peer-reviewed journals and several book chapters in cardiovascular textbooks; he is an Associate Editor of the European Journal of Heart Failure.
In this video, Alex discusses his role as a Cardiologsist in managing CML patients on a TKI (Tyrosine Kinase Inhibitor). He reviews patients before, during and after treatment working in close communication and collaboration with the multi-disciplinary team with the underlying goal of keeping patients on treatment for as long as possible whilst minimising cardiovascular disease. He discusses recommended tests and interventions as well risk factors to be aware of.
PP-BOS-GBR-0980. April 2020